Medical Cannabis Market Expected to Progress

Thursday, December 14, 2017 Drug News
Email Print This Page Comment bookmark
Font : A-A+ News Commentary

NEW YORK, December 13, 2017 /PRNewswire/ --

According to a report

by New Frontier Data, the legal cannabis market was worth $6.6 billion in 2016 and is forecast to grow to $24.1 billion by 2025 with a compound annual growth rate of 16 percent.  Chronic pain
is the largest cause of opioid drug abuse.  Along with chronic pain, sleep disorders, post-traumatic stress disorder (PTSD), nerve pain, anxiety, glaucoma, chemotherapy induced nausea and vomiting (CINV), Tourette syndrome, and seizures/epilepsy, are conditions appointed by the National Academies of Sciences as being best treated by medical cannabis.  Medical cannabis has been successful in lowering prescription drug use in states that it is legal.  The medical cannabis market was worth $4.7 billion in 2016 and is expected to grow to $13.3 billion by 2025.  Adult sales during the same period are projected to grow at a 21 percent CAGR, from $1.9 billion to $10.9 billion. Sugarmade, Inc. (OTC: SGMD), Terra Tech Corp. (OTC: TRTC), United Cannabis Corporation (OTC: CNAB), OWC Pharmaceutical Research Corp. (OTC: OWCP), MassRoots, Inc. (OTC: MSRT)  

State budget deficits may be solved as cannabis revenue could raise a substantial amount and provide state leaders with increased capacity in their budgets.  New Frontier Data CEO Giadha Aguirre De Carcer said, "During this tough economy states are looking for any way to close their budget shortfalls and it appears that cannabis may hold an answer for them. New Frontier Data looked at the potential revenues that could be generated from state cannabis taxes and found that in this year alone, states could raise nearly $750 million and triple that number by 2020. These revenues will have a meaningful impact on state programs and provide governors with much needed breathing room in their budgets."

Sugarmade, Inc. (OTC: SGMD) announced breaking news yesterday that, "an important step toward the introduction of the patented BudLife cannabis storage system. The Company has entered live prototype testing of cannabis flowers in various versions of BudLife, the first container system that maintains the integrity of cannabis flowers for up to six months.

"This week we effectively put these cannabis samples to sleep in modified, optimal atmospheres within the containers. We will closely monitor the samples over the coming days in order to determine the effects. Thus far, results in the laboratory have been impressive and we aim to replicate such results within our live testing environment. The samples are being stored in conditions similar to how we believe consumers would also store cannabis. With the California market opening to recreational purchases in only one month, we believe this final prototype testing is optimally timed," commented Jimmy Chan, CEO of Sugarmade.

After many iterations and modifications to the patented technologies, Plantation, Corp., which is Sugarmade's manufacturing partner, has come up with what it believes is the optimum storage atmosphere for cannabis flowers. BudLife products will preserve the important properties of cannabis THC levels, terpene quality, and trichome structure, along with aroma and feel.

"We are honored to be the exclusive distributor for BudLife products for the single largest cannabis market in the world, the U.S. states of California, Oregon and Washington," continued, Mr. Chan. "We believe this breakthrough is really important. With the growing glut of cannabis flowers in the marketplace, storage will be more critical than ever. As the California market opens up, we expect to see even more cannabis hit the market. We plan to help the cannabis industry deal with this supply issue via high quality preservation and storage products. We look forward to releasing pricing and final versions, and to begin to take pre-orders for these patented and trade secret protected products. We urge all of our investors to visit to review this groundbreaking cannabis storage technology."

The quality of cannabis has risen dramatically over the past few years and it's clear that premium product keeps consumers happy and allows growers and distributors to command premium prices. But, the quality of cannabis degrades quickly, which places the significant investments made in high quality product production at risk. BudLife products are design to significantly reduce this risk and to allow growers and distributors to store and control the release of their higher quality products at optimal times in order to maximize profits, thus helping users of BudLife to shape the cannabis supply and demand curve."

Terra Tech Corp. (OTCQX: TRTC) is a vertically integrated cannabis-focused agriculture company. On November 9, 2017, the company announced its third quarter 2017 financial results for the period ended September 30, 2017. Total revenues generated for the third quarter ended September 30, 2017 were $10.1 million, compared to $7.0 million in the same period in 2016. The increase was driven by sales in the cannabis segment which increased 81.8%, due to higher sales from the Company's four Nevada-based Blüm Dispensaries. It was partially offset by lower sales from Edible Garden due to the discontinuation of sales of its low-margin floral products. United Cannabis Corporation (OTCQB: CNAB) is a biotechnology company dedicated to the development of phyto-therapeutic based products supported by patented technologies for the pharmaceutical, medical, and industrial markets. On October 12, 2017, the company announced that Jamaica's Ministry of Health has registered its Prana CBD-Infused Water as a medicinal cannabis product. The Prana Water will be manufactured and distributed by the Company's Jamaican subsidiary, Cannabinoid Research & Development Limited ("CRD"). CRD has already begun preliminary work to initiate production of other United Cannabis products in Jamaica, including its Prana P5 Hemp Bio Nutrient Capsules, Aromatherapy Roll-On, and Sublingual Drops. OWC Pharmaceutical Research Corp. (OTCQB: OWCP) is engaged in the business, through its wholly-owned Israeli subsidiary, One World Cannabis Ltd., of conducting medical research and clinical trials, in full compliance with all international regulatory protocols, for the development of cannabis-based products and treatments specifically designed for multiple myeloma, psoriasis, fibromyalgia, PTSD, migraines, and of a unique delivery system. Earlier this year, the company announced that its subsidiary, One World Cannabis Ltd., has filed a patent application with the European Union Patent and Trademark Office for its active cannabinoid-based psoriasis topical cream. This action by OWC is a key step in the Company's continuing program to fully protect its intellectual property ("IP"). OWC's strategy in seeking to fully protect its IP, including the filing of this European patent application will enable the Company to accelerate its ongoing discussions and negotiations regarding scientific, medical and commercial collaboration. MassRoots, Inc. (OTCQB: MSRT) is one of the leading technology platforms for the regulated cannabis industry. Recently, the company announced the early-stage testing of a new concierge service for cannabis enthusiasts. The service will be available in early December 2017 and marks a new partnership with Diem Cannabis, an Oregon-based dispensary and delivery service. Early tests will be available throughout Portland and nearby Salem, providing delivery customers with a virtual budtender to help them choose the right order for their specific needs. MassRoots' new concierge service will allow consumers to speak by phone or text chat with a virtual budtender, ask questions, get recommendations, and verify all information is correct before MassRoots hands the order off to Diem, which will fulfill and deliver the final order to the consumer, accepting payment on delivery. Diem currently accepts cash, debit, and eCheck.

Subscribe Now! Watch us report from NYSE

Follow us on Twitter for real time Financial News Updates:

Follow and talk to us on Instagram:

Facebook Like Us to receive live feeds:

About, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, creates 100% unique original content. also provides financial news PR dissemination, branding, marketing and advertising for third parties for corporate news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.

Please Note: is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on (the 'Site') is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content),, a financial news media and marketing firm enters into media buys or service agreements with the companies which are the subject to the articles posted on the Site or other editorials for advertising such companies. has not been compensated directly by any of the companies mentioned here in this editorial. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. receives fees for producing and presenting high quality and sophisticated content on along with other financial news PR media services. does not offer any personal opinions, recommendations or bias commentary as we purely incorporate public market information along with financial and corporate news. only aggregates or regurgitates financial or corporate news through our unique financial newswire and media platform. For this release, has been compensated four thousand dollars for financial news dissemination and pr services by meridian ventures for sugarmade inc. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this editorial or site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. will always disclose any compensation in securities or cash payments for financial news dissemination and PR advertising. does not undertake to update any of the information on the editorial or Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security., members and affiliates are not responsible for any gains or losses that result from the opinions expressed on this editorial or Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. By accessing this editorial and website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use, please visit: . 

For further information:

Media Contact: , +1-877-601-1879




Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store